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Gentamicin (GM) is a widely used antibiotic against serious and life-threatening infections, but its usefulness is limited by
the development of nephrotoxicity. The present study was designed to determine the protective eﬀect of salicylic acid (SA) in
gentamicin-induced nephrotoxicity in rats. Quantitative evaluation of gentamicin-induced structural alterations and degree of
functionalalterationsinthekidneyswereperformedbyhistopathologicalandbiochemicalanalysesinordertodeterminepotential
beneﬁcial eﬀects of SA coadministration with gentamicin. Gentamicin was observed to cause a severe nephrotoxicity which
was evidenced by an elevation of serum urea and creatinine levels. The signiﬁcant increases in malondialdehyde (MDA) levels
and protein carbonyl groups indicated that GM-induced tissue injury was mediated through oxidative reactions. On the other
hand, simultaneous SA administration protected kidney tissue against the oxidative damage and the nephrotoxic eﬀect caused
by GM treatment. Exposure to GM caused necrosis of tubular epithelial cells. Necrosis of tubules was found to be prevented by
SA pretreatment. The results from our study indicate that SA supplement attenuates oxidative-stress associated renal injury by
reducing oxygen free radicals and lipid peroxidation in gentamicin-treated rats.
1.Introduction
Gentamicin (GM) is commonly applied in human clinical
practices for treatment of life-threatening gram-negative
infections [1, 2]. However, the usefulness of GM is limited
by the development of nephrotoxicity. In some cases, this
side eﬀect is so severe that the use of the drug must be
discontinued. In spite of the introduction of newer and less
toxic antibiotics, GM is still used clinically because of its
rapid bactericidal action, broad-spectrum activity, chemical
stability, and low cost [3, 4]. GM-induced nephrotoxicity is
characterizedbydirecttubularnecrosis,withoutmorpholog-
ical changes in glomerular structures [1]. The mechanisms
involved in GM-induced cell injury are not clearly under-
stood. However, several studies demonstrated that reactive
oxygen species (ROS) may be important mediators in GM-
induced nephrotoxicity [5]. Abnormal production of ROS
directly damages some macromolecules and induces cellular
injury and necrosis via several mechanisms including perox-
idation of membrane lipids, protein denaturation, and DNA
damage [6, 7]. Accordingly, the administration of several
compounds with antioxidant activity has been successfully
used to prevent or ameliorate GM-induced nephrotoxicity
[8, 9].
In the past few years, much interest has been laid on the
role of naturally occurring dietary substances for the control
and management of various chronic diseases, one such com-
pound salicylic acid (SA) has been used since ancient times
to provide pain relief and treat inﬂammatory conditions.
Salicylic acid is a phenolic compound present in plants,
where it plays a central role in the development of local and
systemic resistance to pathogen infection [10, 11]. Humans
and animals obtain SA mainly from daily foods, fruits, and2 The Scientiﬁc World Journal
vegetables. Increasing evidence demonstrates that applied
SA can counteract oxidative damage induced by adverse
conditions in animals [12, 13], though the mechanisms
underlying these eﬀects remain unclear. It has been reported
that SA comprise free radical-scavenging and iron chelation
properties [14]. SA can aﬀect the activation of transcription
factors,inparticularnuclearfactorkappaB(NF-κB),thereby
intervening in apoptotic pathways [15]. It is also a hydroxyl
radical scavenger in both experimental animals and humans
who are experiencing oxidative stress [16, 17].
The aim of the present study was therefore to investigate
whether SA treatment prevents GM-induced nephrotoxicity.
For this purpose, we have examined histopathological eﬀects
of GM and possible protective eﬀe c to fS Ao nt i s s u ed a m a g e
of rat kidney. We have also examined tissue malondialdehyde
(MDA) and protein carbonyl levels in order to evaluate lipid
and protein peroxidation, and serum urea and creatinine
levels in order to evaluate renal function.
2.MaterialandMethods
Thirty-two healthy adult female Wistar albino rats weighing
250–300gwererandomlyselectedforthisstudy.Theanimals
were placed in a temperature- (21 ± 2◦C) and humidity-
controlled room with 12-hour light-dark cycles and fed
standard pellet chow and water ad libitum. All experimental
procedures were conducted in accord with the principles
for the care and use of laboratory animals in research and
approvedbythelocalethicscommittee.Alleﬀortsweremade
to minimize animal suﬀering and reduce the number of
animals used.
2.1. Experimental Protocol. After a quarantine period of 7
days, 32 rats were randomly divided into four groups, each
consisting of 8 animals. Group I was used as control and
received1mLofsalineintraperitoneally(i.p.)perday.Group
II received only salicylic acid in single dose of 100mg/kg i.p.
daily. Group III received gentamicin (Galenika AD, Belgrade,
Serbia) on a daily basis in a single dose of 100mg/kg by
i.p. injection. Group IV was given salicylic acid (Sigma, St.
Louis, MO, USA) in a single i.p. dose of 100mg/kg along
with the same dose of gentamicin as the group II each day
throughout the experiment. All groups were treated over a
period of 8 consecutive days. Twenty-four hours after the
administration of last doses of GM and SA, on 9th day, rats
were anesthetized by intraperitoneal injection of ketamine
(Ketamidor 10%, Richter Pharma AG, Wels, Austria) and
sacriﬁced.Renalcorticaltissueswereseparatedintotwoparts
for biochemical analysis and light microscopic examination.
Blood samples were also taken by cardiac puncture to assess
the serum levels of urea and creatinine.
2.2. Biochemical Analysis. Serum urea and creatinine levels
were determined with an automatic biochemical analyzer
(A25 Biosystems, Barcelona, Spain).
For estimation of oxidative stress the kidney tissue was
cut in small pieces and homogenized in ice-cold water, by
using a homogenizer (IKA Works de Brasil Ltda Taquara, RJ
22713–00). The homogenates (10% w/v) were centrifuged at
1500 × g for 10min. at 4◦C.
2.3. Determination of Proteins. Proteins were determined
according to Lowry’s method [18] using bovine serum
albumin as standard.
2.4. Determination of MDA. The intensity of lipid peroxida-
tion in the kidney tissue was spectrophotometrically mea-
sured, based on the thiobarbituric (TBA) response products
[19]. Homogenate absorption was measured at 532nm.
Malondialdehyde-(MDA-)lipid peroxidation end product,
concentration was expressed per mg/protein, using the
molecular extinction coeﬃcient of MDA (1.56 × 10−5mol
cm−1).
2.5. Determination of Protein Oxidation. Carbonyl group
concentration, as the level of oxidative modiﬁed proteins,
was determined spectrophotometrically [20] using 2.4 dini-
trophenylhydrazine, a traditional carbonyl reagent. Reactive
carbonyl derivatives were calculated using the DPNH molar
extinction coeﬃcient at 370nm (22 × 103 L/mol/cm) and
expressed in μmol/g of protein.
2.6. Histopathological Examinations. Histopathological eval-
uation was made in kidney tissues. Kidneys were dissected
immediately and preserved in 10% buﬀered formaldehyde
for further histopathological examinations. Tissue samples
were embedded in paraﬃna n d5 - 6 μms e c t i o n sw e r ec u t
using a rotary microtome and stained with hematoxylin
and eosin (H&E). A minimum of 8 ﬁelds for each kidney
section were examined and assigned for severity of changes
by an observer blinded to the treatments of the animals. All
sections were examined with a Leica DMR (Leica Microsys-
tems AG, Wetzlar, Germany) light microscope. To evaluate
the level of damages, indexes such as tubular degeneration,
tubular necrosis, mononuclear cell inﬁltration, and hyaline
casts were scored numerically. The evaluation criteria were
as follows: 0 for no detectable lesion, 1 for mild changes, 2
for moderate changes, and 3 for severe changes.
2.7.StatisticalAnalysis. Resultswereexpressedasthemean ±
SD. Statistical signiﬁcant diﬀerence was determined by one-
way analysis of variance (ANOVA) followed by Tukey’s post
hoc test for multiple comparison (Graphpad Prism version
5.03, San Diego, CA, USA). Probability values (P) less than
0.05 were considered to be statistically signiﬁcant.
3. Results
3.1. Eﬀe c to fS Ao nS e r u mC r e a t i n i n ea n dU r e aL e v e l si n
Gentamicin-Treated Rats. GM treatment for eight days re-
sulted in signiﬁcant increase in serum creatinine and urea
compared to control rats (Table 1). However, elevations
in the serum creatinine and blood urea were signiﬁcantly
(P<0.001) attenuated by SA pretreatments, indicating
reduction in GM-induced nephrotoxicity (P<0.01, resp.).
SA treatment alone did not change the renal function tests,
when compared to control values (Table 1).The Scientiﬁc World Journal 3
Table 1: Eﬀects of salicylic acid on gentamicin-induced renal dysfunction as measured by levels of serum urea and creatinine.
Parameters Control SA GM GM + SA
Urea (mmol/L) 5.60 ±0.91
∗ 5.20 ±0.66
∗ 18.91 ±2.86 9.53 ±1.43#
Creatinine (μmol/L) 48.63 ±2.34# 51.75 ±8.26# 71.71 ±9.43 55.88 ±8.82#
Data are presented as mean ± SD.































Figure 1: Eﬀect of gentamicin (GM), salicylic acid (SA) and their
combination on malondialdehyde (MDA) levels in kidney tissues of
rats. Values are means ± SD. ∗P<0.001 versus Control, SA and
GM.
3.2. Eﬀect of SA on Renal Oxidative Stress in Gentamicin-
Treated Rats. TissueMDAwassigniﬁcantlyincreased(7.36±
0.45μmol/mg) in the GM-treated renal injury group, when
compared to the control group (6.07 ± 0.54μmol/mg; P<
0.001). The increases induced by GM were completely
prevented by SA administrations (GM + SA group). The
MDA contents were found similar in the control and SA
groups (Figure 1).
GM treatment induced a signiﬁcant increase in the
protein carbonyl content in renal tissue compared to the
control group (Figure 2). Renal protein carbonyl content of
the GM group (14.99 ± 2.58μmol/mg) was attenuated by
treatment with SA (10.12 ± 3.27μmol/mg; P<0.01). SA
treatment alone did not cause a signiﬁcant eﬀect on protein
carbonyl content of the control group (Figure 2).
3.3. Histopathological Analysis. The histopathological chan-
gesinkidneysinallgroupsaresummarizedinTable 2.Light-
microscopic examination of kidneys from control and SA-
treated rats showed no structural alterations in renal tissues
(Figures 3(a) and 3(b)). Massive and diﬀuse cell necrosis
was observed in the proximal tubules of kidneys from rats
injected with gentamicin. In addition, the lumens of these
tubules were ﬁlled with degenerate and desquamated epithe-
lial cells and hyaline casts. Severe inﬂammatory inﬁltrate
in the form of mononuclear cells were observed in the
r e n a ls e c t i o n so ft h i sg r o u p( Figure 3(c)). Kidney specimens
from rats treated with GM and SA revealed signiﬁcant












































Figure 2: Eﬀect of gentamicin (GM), salicylic acid (SA), and their
combination on protein carbonyl content in kidney tissues of rats.
Valuesaremeans ±SD. ∗P<0.001versuscontrolandSA; #P<0.01
versus GM.
Table 2: Grading of histopathological changes in the kidney
sections.
Histopathological changes Control SA GM GM + SA
Mononuclear cell inﬁltration — — +++ +
Tubular degeneration — — +++ +
Tubular necrosis — — ++ —
Hyaline casts in tubular lumen — — + —
Scoringwasdoneasfollows:none(—),mild(+),moderate(++),andsevere
(+++).
preservation of tubular histology compared with the GM-
treated group (Figure 3(d)).
4. Discussion
Aminoglycoside antibiotic GM is commonly used for the
treatment of severe gram-negative bacterial infections [21].
However, nephrotoxicity is a major complication of GM
administration. Thus amelioration of nephrotoxicity would
enhance its clinical use. Several approaches involving the
use of chemical compounds have been used to reduce GM
nephrotoxicity [7, 22]. Phenolic compounds from dietary
plants are known to be good scavengers of reactive oxygen
species.Inthepastfewdecades,aconsiderableandconsistent
amount of evidence has demonstrated that SA has antioxi-
dant properties [23, 24], though the mechanisms underlying
these eﬀects remain unclear. Firstly, it has been reported
that salicylates comprise free radical-scavenging and iron
chelation properties [14]. Also, it has been demonstrated4 The Scientiﬁc World Journal
(a) (b)
(c) (d)
Figure 3: Photomicrograph of rat kidney section. (a and b) Normal histology of kidney tissue in control and SA-treated rats (H&E ×200).
(c) Marked tubular necrosis (asterisk) and massive mononuclear cell inﬁltration (arrow) in cortex of rats in GM-group (H&E ×200). (d)
Section from rat treated with gentamicin (100mg/kg) plus salicylic acid (100mg/kg) reveal almost complete prevention of histopathological
alterations (H&E ×200).
thatsalicylateeﬀectivelyprotectsagainstgentamicin-induced
hearing loss in guinea pigs [25]. Thus in the present
study, we assessed whether the nephrotoxic eﬀects caused
by acute administration of GM could be prevented or
amelioratedbytreatmentwithSA,aherbalcompoundwhich
possesses a strong antioxidant property [23]. Several dosage
schemes have been reported for GM administration and an
intraperitoneal (i.p.) dose of 100mg/kg body weight, for 8
days, was used which is a dosage scheme reported to cause
signiﬁcant nephrotoxicity in rats [26].
The results of this study show that GM administration
to rats produced a typical pattern of nephrotoxicity which
was manifested by marked increase in serum creatinine and
urea levels. On the other hand, SA administration showed
a signiﬁcant decrease in the levels of serum creatinine and
urea. The curative eﬀect of SA on the kidney markers can
be attributed to its antioxidant property as it has been
found that ROS may be involved in the impairment of
glomerular ﬁltration rate (GRF) [27]. Low or moderate
production of ROS plays a physiological role in several
redox-responsive signaling pathways, for example, in defense
against environmental pathogens, regulation of vascular
tone by nitric oxide (NO), regulation of cell adhesion, and
apoptosis [28]. Nevertheless, when these reactive species are
sustainably produced in overwhelming amounts, they may
initiate a wide range of pro-oxidant reactions that result in
damage of cellular macromolecules, including lipid perox-
idation, protein nitration, and oxidation [28]. Formation
of ROS has been shown to increase with GM treatment
[22]. This evolution of ROS would stimulate the activation
or expression of proinﬂammatory mediators, including NF-
κB, leukocyte adhesion molecules, and mitogen-activated
protein kinases (MAPKs) [29], which contribute to progres-
sive kidney damage induced by GM. Recent studies have
shown that redox-sensitive transcription factors, MAPK and
NF-kB, are involved in nephrotoxicity caused by GM [30,
31]. NF-κB is a highly conserved family of transcription
factors that has a critical role in mediating inﬂammation,
apoptosis, and growth in chronic disease [32]. Activation
of NF-κB, in response to oxidative stress might play a
role in GM-induced nephrotoxicity by inducing synthesis
of inﬂammatory substances (cytokines, growth factors, and
adhesionmolecules)thatprovokekidneydamage[33].Thus,
blockade of NF-κBw i l lb ea ne ﬀective approach for the
treatment of nephrotoxicity.
SA has been shown to block NF-kB-mediated gene
expression at suprapharmacological concentrations [34]. In
LPS-stimulated cells, SA blocked the LPS-induced phospho-
rylation and proteolysis of inhibitors of kB (IκB), which
suggests that the inhibition of NF-κB was mediated through
the inactivation of the classical signaling pathway [34].
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indicates that their anti-inﬂammatory activity is partially
related to the inhibition of this transcription factor.
As expected, MDA and carbonyl group levels increased
signiﬁcantly in the kidney of rats exposed to GM com-
pared to the control group. These oxidative stress-related
alterations, which are in agreement with previous reports
[35], were attenuated by SA administration. A plausible
justiﬁcation for this protection conferred by SA is its potent
scavenging eﬀect on hydroxyl radical (HO·). Among ROS,
HO· is thought to be the most damaging species and the one
mainly responsible for lipid and protein oxidation [36].
These ﬁndings correlated well with the histological
examination, which revealed tubular necrosis especially in
the renal cortex (Table 2). The kidneys of the control
group showed normal histological features (Figure 3(a)),
but the GM-treated group revealed more extensive and
marked tubular necrosis. There were leukocytic inﬁltrations
considered,asaprominentresponseofthebodytissuefacing
any injurious impacts (Figure 3(c)). These modiﬁcations
could be due to the accumulation of free radicals resulting
from an increased lipid peroxidation in the renal tissues of
the GM-treated group. Renal lesions were also characterized
by vascular congestion as well as tubular obstruction. Similar
changes were also reported by Kumar et al. [37]a n d
Stojiljkovic et al. [38] who demonstrated structural changes
in renal tissue of GM-treated animals and its reversal by
various agents. Glomerular and tubular epithelial changes
were considerably mild in the group treated with both GM +
SA (Figure 3(d)), thus showing curative eﬀect of SA against
GM-induced tissue damage.
Besides their direct damaging eﬀects on tissues, free
radicals seem to trigger the accumulation of leukocytes
in the tissue involved, and thus cause tissue injury also
indirectly through activated neutrophils. It has been shown
that activated neutrophils secrete enzymes (e.g., myeloper-
oxidase, elastase, and proteases) and liberate oxygen radicals
[39]. Increasing evidence suggests that mesangial cells and
neutrophils release chemotactic substances (e.g., interleukin
8), which further promote neutrophil migration to the
kidney, activate neutrophils, and increase glomerular injury
[40].Theseresultssuggestthatneutrophilsplayanimportant
role in mediating tissue injury with subsequent renal failure
[41]. Oxidative stress and inﬂammation are inextricably
linked as one begins and ampliﬁes the other. In this
context, oxidative stress invariably recruits inﬂammation via
activation of NF-κB, which is the general transcription factor
for various proinﬂammatory cytokines, chemokines, and
adhesionmolecules.Productionofthesemediatorspromotes
leukocyte/macrophage adhesion, activation, inﬁltration, and
ROS production. The latter, in turn, accentuate the inciting
oxidativestress.Conversely,releaseofROS,reactivechlorine,
nitrogen, and other species by activated leukocytes and
macrophages in the course of the primary inﬂammation
results in oxidative stress [42].
5. Conclusion
The results of this study conﬁrm the earlier reports that
GM-treatedratsshowacceleratedlipidandproteinoxidation
in the renal tissue, as reﬂected by an increase in MDA
and protein carbonyl groups. Pretreatment with SA aﬀorded
signiﬁcant protection against nephrotoxicity induced by GM
treatment. The beneﬁcial eﬀect of SA in GM toxicity implies
the involvement of free radicals in the renal damage. Accord-
ing to our biochemical ﬁndings, which were supported by
histopathological evidence, administration of SA abolished
nephrotoxic eﬀects of GM. These ﬁndings indicate that SA
supplementation may reduce GM-induced renal injury. We
propose that salicylic acid modulates oxidative stress and
associated potentially proinﬂammatory activity in the kid-
ney. This may be via mechanisms linked to redox signaling,
through an eﬀective inhibition of proinﬂammatory factors,
scavenging of ROS, and inhibition of NF-κB.
Acknowledgment
This paper was supported by the Ministry of Science and
Technological Development, Republic of Serbia, Grants
43012, 175092, and 172061.
References
[1] I. Karahan, A. Ates ¸s ¸ahin, S. Yilmaz, A. O. C ¸e ribas ¸i, and F.
Sakin, “Protective eﬀect of lycopene on gentamicin-induced
oxidative stress and nephrotoxicity in rats,” Toxicology, vol.
215, no. 3, pp. 198–204, 2005.
[2] W. Mwengee, T. Butler, S. Mgema et al., “Treatment of plague
with gentamicin or doxycycline in a randomized clinical trial
in Tanzania,” Clinical Infectious Diseases,v o l .4 2 ,n o .5 ,p p .
614–621, 2006.
[3] W. E. Siegenthaler, A. Bonetti, and R. Luthy, “Aminoglycoside
antibiotics in infectious diseases. An overview,” American
Journal of Medicine, vol. 80, no. 6, pp. 2–14, 1986.
[4] T. H. Mathew, “Drug-induced renal disease,” Medical Journal
of Australia, vol. 156, no. 10, pp. 724–728, 1992.
[5] A.A.Banday,N.Farooq,S.Priyamvada,A.N.K.Yusuﬁ,andF.
Khan, “Time dependent eﬀects of gentamicin on the enzymes
of carbohydrate metabolism, brush border membrane and
oxidative stress in rat kidney tissues,” Life Sciences, vol. 82, no.
9-10, pp. 450–459, 2008.
[6] R. Baliga, Z. Zhang, M. Baliga, N. Ueda, and S. V. Shah,
“In vitro and in vivo evidence suggesting a role for iron in
cisplatin-induced nephrotoxicity,” Kidney International, vol.
53, no. 2, pp. 394–401, 1998.
[7] H. Parlakpinar, S. Tasdemir, A. Polat et al., “Protective role
of caﬀeic acid phenethyl ester (cape) on gentamicin-induced
acuterenaltoxicityinrats,”Toxicology,vol.207,no.2,pp.169–
177, 2005.
[8] N. Stojiljkovic, M. Stoiljkovic, P. Randjelovic, S. Veljkovic,
and D. Mihailovic, “Cytoprotective eﬀect of vitamin C against
gentamicin-induced acute kidney injury in rats,” Experimental
and Toxicologic Pathology, vol. 64, no. 1-2, pp. 69–74, 2012.
[9] B. H. Ali, “Agents ameliorating or augmenting experimental
gentamicin nephrotoxicity: some recent research,” Food and
Chemical Toxicology, vol. 41, no. 11, pp. 1447–1452, 2003.
[10] D. A. Dempsey and D. F. Klessig, “Salicylic acid, active oxygen
species and systemic acquired resistance in plants,” Trends in
Cell Biology, vol. 4, no. 9, pp. 334–338, 1994.
[11] J. Dangl, “Plants just say NO to pathogens,” Nature, vol. 394,
no. 6693, pp. 525–527, 1998.6 The Scientiﬁc World Journal
[12] A.Guerrero ,J .A.Gonz´ alez-Correa,M.M.Arrebola,J.Mu˜ noz-
Mar´ ın, F. S´ anchez De La Cuesta, and J. P. De La Cruz,
“Antioxidant eﬀects of a single dose of acetylsalicylic acid
and salicylic acid in rat brain slices subjected to oxygen-
glucose deprivation in relation with its antiplatelet eﬀect,”
Neuroscience Letters, vol. 358, no. 3, pp. 153–156, 2004.
[13] R. J. Dinis-Oliveira, C. Sousa, F. Remi˜ ao et al., “Full survival of
paraquat-exposed rats after treatment with sodium salicylate,”
Free Radical Biology and Medicine, vol. 42, no. 7, pp. 1017–
1028, 2007.
[14] O. I. Aruoma and B. Halliwell, “The iron-binding and
hydroxyl radical scavenging action of anti-inﬂammatory
drugs,” Xenobiotica, vol. 18, no. 4, pp. 459–470, 1988.
[15] M. J. Yin, Y. Yamamoto, and R. B. Gaynor, “The anti-
inﬂammatory agents aspirin and salicylate inhibit the activity
of IκB kinase-β,” Nature, vol. 396, no. 6706, pp. 77–80, 1998.
[16] A.Ghiselli,O.Laurenti,G.DeMattia,G.Maiani,andA.Ferro-
Luzzi, “Salicylate hydroxylation as an early marker of in vivo
oxidative stress in diabetic patients,” Free Radical Biology and
Medicine, vol. 13, no. 6, pp. 621–626, 1992.
[17] S. R. Powell, “Salicylate trapping of ·OH as a tool for studying
post-ischemic oxidative injury in the isolated rat heart,” Free
Radical Research, vol. 21, no. 6, pp. 355–370, 1994.
[18] O. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randall,
“Protein measurement with the Folin phenol reagent,” The
Journal of biological chemistry, vol. 193, no. 1, pp. 265–275,
1951.
[19] H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides
in animal tissues by thiobarbituric acid reaction,” Analytical
Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.
[20] R. L. Levine, J. A. Williams, E. R. Stadtman, and E. Shacter,
“Carbonyl assays for determination of oxidatively modiﬁed
proteins,”Methods in Enzymology, vol.233,pp.346–357, 1994.
[ 2 1 ]R .J .R e i t e r ,D .X .T a n ,R .M .S a i n z ,J .C .M a y o ,a n dS .L o p e z -
Burillo, “Melatonin: reducing the toxicity and increasing the
eﬃcacy of drugs,” Journal of Pharmacy and Pharmacology, vol.
54, no. 10, pp. 1299–1321, 2002.
[22] S. Cuzzocrea, E. Mazzon, L. Dugo et al., “A role for superoxide
in gentamicin-mediated nephropathy in rats,” European Jour-
nal of Pharmacology, vol. 450, no. 1, pp. 67–76, 2002.
[23] M. T. Baltazar, R. J. Dinis-Oliveira, J. A. Duarte, M. L. Bastos,
and F. Carvalho, “Antioxidant properties and associated
mechanisms of salicylates,” Current Medicinal Chemistry, vol.
18, no. 21, pp. 3252–3264, 2011.
[24] A. Colantoni, N. De Maria, P. Caraceni, M. Bernardi, R. A.
Floyd, and D. H. Van Thiel, “Prevention of reoxygenation
injury by sodium salicylate in isolated-perfused rat liver,” Free
Radical Biology and Medicine, vol. 25, no. 1, pp. 87–94, 1998.
[25] S. H. Sha and J. Schacht, “Salicylate attenuates gentamicin-
induced ototoxicity,” Laboratory Investigation,v o l .7 9 ,n o .7 ,
pp. 807–813, 1999.
[26] N. Stojiljkovic, D. Mihailovic, S. Veljkovic, M. Stoiljkovic, and
I. Jovanovic, “Glomerular basement membrane alterations
induced by gentamicin administration in rats,” Experimental
and Toxicologic Pathology, vol. 60, no. 1, pp. 69–75, 2008.
[27] A. K. Hughes, P. K. Stricklett, E. Padilla, and D. E. Kohan,
“Eﬀect of reactive oxygen species on endothelin-1 production
byhumanmesangialcells,” KidneyInternational,v ol.49,no .1,
pp. 181–189, 1996.
[28] M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M.
Mazur, and J. Telser, “Free radicals and antioxidants in normal
physiological functions and human disease,” International
Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–
84, 2007.
[29] W. W. Tang, L. Feng, J. C. Mathison, and C. B. Wilson,
“Cytokine expression, upregulation of intercellular adhesion
molecule-1, and leukocyte inﬁltration in experimental tubu-
lointerstitial nephritis,” Laboratory Investigation, vol. 70, no. 5,
pp. 631–638, 1994.
[30] V. Tugcu, E. Ozbek, A. I. Tasci et al., “Selective nuclear factor
κ-B inhibitors, pyrolidium dithiocarbamate and sulfasalazine,
prevent the nephrotoxicity induced by gentamicin,” BJU
International, vol. 98, no. 3, pp. 680–686, 2006.
[31] R. A. Volpini, A. P. C. Balbi, R. S. Costa, and T. M. Coimbra,
“Increased expressionofp38mitogen-activated proteinkinase
is related to the acute renal lesions induced by gentamicin,”
Brazilian Journal of Medical and Biological Research, vol. 39,
no. 6, pp. 817–823, 2006.
[32] E. N. Wardle, “Nuclear factor κB for the nephrologist,”
Nephrology Dialysis Transplantation, vol. 16, no. 9, pp. 1764–
1768, 2001.
[33] N. Li and M. Karin, “Is NF-κB the sensor of oxidative stress?”
FASEB Journal, vol. 13, no. 10, pp. 1137–1143, 1999.
[34] E. Kopp and S. Ghosh, “Inhibition of NF-κBb ys o d i u m
salicylateandaspirin,”Science,vol.265,no.5174,pp.956–959,
1994.
[35] F. Petronilho, L. Constantino, B. De Souza et al., “Eﬃcacy
of the combination of N-acetylcysteine and desferrioxamine
in the prevention and treatment of gentamicin-induced
acute renal failure in male Wistar rats,” Nephrology Dialysis
Transplantation, vol. 24, no. 7, pp. 2077–2082, 2009.
[36] H. Kaur and B. Halliwell, “Detection of hydroxyl radicals by
aromatic hydroxylation,” Methods in Enzymology, vol. 233, pp.
67–82, 1994.
[37] K. V. Kumar, A. A. Shifow, M. U. R. Naidu, and K. S. Ratnakar,
“Carvedilol: a beta blocker with antioxidant property protects
against gentamicin-induced nephrotoxicity in rats,” Life Sci-
ences, vol. 66, no. 26, pp. 2603–2611, 2000.
[38] N. Stojiljkovic, S. Veljkovic, D. Mihailovic et al., “Protective
eﬀects of pentoxifylline treatment on gentamicin-induced
nephrotoxicity in rats,” Renal Failure, vol. 31, no. 1, pp. 54–61,
2009.
[39] A. J. Kettle and C. C. Winterbourn, “Myeloperoxidase: a key
regulator of neutrophil oxidant product,” Redox Report, vol. 3,
no. 1, pp. 3–15, 1997.
[40] R. J. Reiter, D. X. Tan, C. Osuna, and E. Gitto, “Actions
of melatonin in the reduction of oxidative stress: a review,”
Journal of Biomedical Science, vol. 7, no. 6, pp. 444–458, 2000.
[41] K. K. Donnahoo, X. Meng, A. Ayala, M. P. Cain, A. H. Harken,
and D. R. Meldrum, “Early kidney TNF-α expression medi-
ates neutrophil inﬁltration and injury after renal ischemia-
reperfusion,” American Journal of Physiology, vol. 277, no. 3,
pp. R922–R929, 1999.
[42] J. Anrather, G. Racchumi, and C. Iadecola, “NF-κB regulates
phagocytic NADPH oxidase by inducing the expression of
gp91phox,” Journal of Biological Chemistry, vol. 281, no. 9, pp.
5657–5667, 2006.